Posts in category: Uncategorized

By NATION REPORTER

GOVERNMENT says it is working closely with the private sector in order to mitigate the cost of fuel pump prices in the country emphasizing that it is not just sitting idle.

Centenarians, once considered rare, have become commonplace. Indeed, they are the fastest-growing demographic group of the world’s population, with numbers roughly doubling every ten years since the 1970s.

Antibiotic use in neonatal intensive care units (NICUs) has decreased substantially over the past decade, according to researchers at Children’s Hospital of Philadelphia (CHOP). The findings, published in a research letter in JAMA Pediatrics, may reflect the success of antibiotic stewardship efforts focused on the use of antibiotics in hospitalized newborns.

Every eight minutes, a child experiences a medication error at home. These mistakes can be life-threatening.

An American born in 2019 will spend a larger share of their lifetime taking prescription drugs than being married or receiving an education, according to new research by Jessica Ho, associate professor of sociology and demography at Penn State. She found that American males will spend approximately 48% of their lives taking prescription drugs. The number jumped to 60% for females.

By ROGERS KALERO

SECRETARY to the Treasury Felix Nkulukusa has challenged commercial banks to explain why interest rates have continued to remain high despite government having stopped from borrowing from the local market.

In cases where standard therapies fail, a medication called XEN1101 reduces seizure frequency by more than 50% in some patients and sometimes eliminates them altogether, a new study shows. Unlike several treatments that must be started at low doses and slowly ramped up, the new drug can safety be taken at its most effective dose from the start, the authors say.

A new combination of treatments safely decreased growth of pancreatic cancer in mice by preventing cancer cells from scavenging for fuel, a new study finds.

Liquid biopsies are blood tests that can serially measure circulating tumor DNA (cell-free DNA that is shed into the bloodstream by dying cancer cells). When used in patients with advanced non-small cell lung cancer undergoing immunotherapy, they may identify patients who could benefit from treatment with additional drugs, according to a phase 2 clinical trial in the U.S. and Canada.

Cancer survivors have a significantly higher prevalence of hearing loss (HL) than the general population, according to a study published online Oct. 5 in JAMA Otolaryngology-Head and Neck Surgery.